Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lupin And Mark Cuban Shake Hands On Spiriva Alliance In US
Indian Firm Recently Launched First Generic; Aiming For 40%+ Share
Sep 15 2023
•
By
Dean Rudge
Lupin has struck a deal with the Mark Cuban Cost Plus Drug Company • Source: Shutterstock
More from Deals
More from Business